MedTrace Logo

ANRS 12406 EvvA Study

NCT04593979 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 289

Last updated 2021-04-30

No results posted yet for this study

Summary

ANRS 12406 EvvA is an observational, longitudinal and monocentric study evaluating the virological success rate in HIV-infected adolescents on antiretroviral therapy in Cameroon.

The main objective of the study is to estimate the rate of virological suppression among adolescents on antiretroviral therapy for more than 6 months in Cameroon

Conditions

Sponsors & Collaborators

  • Hospital Laquinitinie de Douala

    collaborator UNKNOWN

  • Franceville International Center for Medical Research, Gabon

    collaborator UNKNOWN

  • Institut Pasteur

    collaborator INDUSTRY

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Principal Investigators

  • Avelin F AGHOKENG, PhD · Institut de Recherche pour le Developpement

  • Ida C PENDA · Hôpital Laquinitie de Douala

Eligibility

Min Age
10 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-15
Primary Completion
2022-01-14
Completion
2022-01-14

Countries

  • Cameroon

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04593979 on ClinicalTrials.gov